Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Knee
Double-Blind Method
Double-Blind Method
Enoxaparin
Enoxaparin
Fibrinolytic Agents
Fibrinolytic Agents
Humans
Humans
Middle Aged
Middle Aged
Postoperative Complications
Postoperative Complications
Postoperative Period
Postoperative Period
Prospective Studies
Prospective Studies
Thromboembolism
Thromboembolism
Venous Thrombosis
Venous Thrombosis
authors with profiles
Philip Cinnamon Comp